Literature DB >> 26365757

Adiposity and risk of thyroid cancer: a systematic review and meta-analysis.

D Schmid1, C Ricci1, G Behrens1, M F Leitzmann1.   

Abstract

Thyroid cancer incidence has increased rapidly over time, as has obesity prevalence. A link between the two appears plausible, but the relation of adiposity to thyroid cancer remains incompletely understood. We performed a meta-analysis of adiposity measures and thyroid cancer using studies identified through October 2014. Twenty-one articles yielded data on 12,199 thyroid cancer cases. We found a statistically significant 25% greater risk of thyroid cancer in overweight individuals and a 55% greater thyroid cancer risk in obese individuals as compared with their normal-weight peers. Each 5-unit increase in body mass index (BMI), 5 kg increase in weight, 5 cm increase in waist or hip circumference and 0.1-unit increase in waist-to-hip ratio were associated with 30%, 5%, 5% and 14% greater risks of thyroid cancer, respectively. When evaluated by histologic type, obesity was significantly positively related to papillary, follicular and anaplastic thyroid cancers, whereas it revealed an inverse association with medullary thyroid cancer. Both general and abdominal adiposity are positively associated with thyroid cancer. However, relations with BMI vary importantly by tumour histologic type.
© 2015 World Obesity.

Entities:  

Keywords:  Adiposity; meta-analysis; thyroid cancer

Mesh:

Year:  2015        PMID: 26365757     DOI: 10.1111/obr.12321

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  66 in total

1.  Cancers attributable to excess body weight in Canada in 2010.

Authors:  Dianne Zakaria; Amanda Shaw
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-07       Impact factor: 3.240

2.  Cancers Due to Excess Weight, Low Physical Activity, and Unhealthy Diet.

Authors:  Gundula Behrens; Thomas Gredner; Christian Stock; Michael F Leitzmann; Hermann Brenner; Ute Mons
Journal:  Dtsch Arztebl Int       Date:  2018-09-03       Impact factor: 5.594

Review 3.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

Review 4.  Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis.

Authors:  Alvaro Sanabria; Luiz P Kowalski; Jatin P Shah; Iain J Nixon; Peter Angelos; Michelle D Williams; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-12-05       Impact factor: 3.147

5.  Changing incidence and projections of thyroid cancer in mainland China, 1983-2032: evidence from Cancer Incidence in Five Continents.

Authors:  Mandi Li; Jiao Pei; Minghan Xu; Ting Shu; Chengjie Qin; Meijing Hu; Yawei Zhang; Min Jiang; Cairong Zhu
Journal:  Cancer Causes Control       Date:  2021-06-21       Impact factor: 2.506

6.  Cell phone use and risk of thyroid cancer: a population-based case-control study in Connecticut.

Authors:  Jiajun Luo; Nicole C Deziel; Huang Huang; Yingtai Chen; Xin Ni; Shuangge Ma; Robert Udelsman; Yawei Zhang
Journal:  Ann Epidemiol       Date:  2018-10-29       Impact factor: 3.797

7.  Pituitary neuroendocrine tumors and differentiated thyroid cancer: do metabolic and inflammatory risk factors play roles?

Authors:  G Cortês Nascimento; A G P de Araujo Cortês Nascimento; C de Maria Ribeiro Veiga Parente; V P Rodrigues; R S de Sousa Azulay; V C de Carvalho Rocha; S da Silva Pereira Damianse; M Magalhães; M Dos Santos Faria; M B Gomes
Journal:  J Endocrinol Invest       Date:  2020-07-17       Impact factor: 4.256

8.  Mps1 is associated with the BRAFV600E mutation but does not rely on the classic RAS/RAF/MEK/ERK signaling pathway in thyroid carcinoma.

Authors:  Yike Li; Yanyan Zhang; Shuaishuai Xiao; Pengzhou Kong; Caixia Cheng; Ruyi Shi; Fang Wang; Ling Zhang; Juan Wang; Zhiwu Jia; Shuai Wu; Yun Liu; Jiansheng Guo; Xiaolong Cheng; Yongping Cui; Jing Liu
Journal:  Oncol Lett       Date:  2018-04-24       Impact factor: 2.967

9.  SPHK1 promotes metastasis of thyroid carcinoma through activation of the S1P/S1PR3/Notch signaling pathway.

Authors:  Zhijing Zhao; Junfeng Ma; Baoquan Hu; Yi Zhang; Shushu Wang
Journal:  Exp Ther Med       Date:  2018-04-12       Impact factor: 2.447

10.  Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer.

Authors:  Sunmi Park; Mark C Willingham; Jun Qi; Sheue-Yann Cheng
Journal:  Endocr Relat Cancer       Date:  2018-06-18       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.